Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Parma › NPI 1164481677
Hospital

Parma Community General Hospital Association

Parma Community General Hospital Association was paid $15.68M by Medicaid between Jan 2018 and Dec 2024, across 283 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.

33Billing provider infoPARMA COMMUNITY GENERAL HOSPITAL ASSOCIATION
PARMA, OH 44129
33aNPI1164481677assigned 03/22/2006
28Total paid$15.68M
24GClaims458,305
24DCodes billed283
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#60 of 101
Median peer was paid$22.32M
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201841,681$1.21M
201932,715$1.12M
202017,128$855K
202126,670$1.21M
202234,847$1.47M
2023169,031$5.47M
2024incomplete136,233$4.35M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 21% 28,445 26,334 $3.22M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 15,280 13,734 $1.88M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 10% 7,409 5,313 $1.59M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.3% 13,279 11,462 $1.46M
96361 Intravenous infusion, hydration; each additional hour 5.9% 3,619 2,836 $919K
70450 Computed tomography, head or brain; without contrast material 4.8% 3,611 2,972 $755K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.3% 5,236 4,618 $525K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.2% 2,431 1,955 $496K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.9% 6,484 2,545 $461K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.7% 4,702 3,896 $421K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.3% 955 819 $206K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 854 692 $192K
271 more codes
80053 Comprehensive metabolic panel 1.2% 26,744 $187K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.1% 924 $179K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.1% 923 $172K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 710 $160K
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.0% 226 $160K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 397 $146K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 2,133 $146K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,630 $129K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 930 $117K
62323 <1% 310 $117K
G0378 Hospital observation service, per hour <1% 1,877 $95K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 593 $94K
97161 <1% 1,594 $72K
80048 Basic metabolic panel (calcium, ionized) <1% 8,359 $71K
99215 Doctor's office visit, returning patient (complex) <1% 769 $70K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,310 $64K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 592 $62K
92550 <1% 657 $57K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 701 $54K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,589 $53K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 514 $48K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 628 $47K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 434 $46K
97113 <1% 620 $45K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,300 $44K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,319 $44K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 521 $41K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 2,718 $37K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 32,248 $37K
71250 <1% 446 $37K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,098 $35K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,417 $34K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,428 $34K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 98 $34K
71046 Radiologic examination, chest; 2 views <1% 4,655 $33K
92557 <1% 786 $31K
77063 Screening digital breast tomosynthesis, bilateral <1% 697 $30K
84484 <1% 8,996 $27K
93971 <1% 422 $26K
97165 <1% 604 $25K
71045 Radiologic examination, chest; single view <1% 5,731 $23K
85027 <1% 6,077 $22K
93017 <1% 287 $21K
36415 Collection of venous blood by venipuncture <1% 24,140 $20K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 45 $20K
76770 <1% 117 $18K
82805 <1% 869 $18K
76830 Ultrasound, transvaginal <1% 563 $16K
86850 <1% 1,046 $15K
76642 <1% 161 $13K
72131 <1% 399 $13K
73562 <1% 291 $13K
73630 <1% 729 $12K
74018 <1% 458 $12K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 42 $11K
84443 Thyroid stimulating hormone (TSH) <1% 1,567 $11K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 9,104 $11K
73030 <1% 550 $10K
95811 <1% 13 $10K
20610 <1% 78 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,315 $9K
80320 <1% 649 $9K
72125 Computed tomography, cervical spine; without contrast material <1% 1,227 $9K
83605 <1% 3,256 $9K
77067 Screening mammography, bilateral, including computer-aided detection <1% 698 $8K
86900 <1% 1,095 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,273 $8K
76536 <1% 80 $7K
82947 <1% 4,613 $7K
12001 <1% 48 $7K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 428 $7K
73130 <1% 584 $7K
73610 <1% 578 $7K
96375 Therapeutic injection; each additional sequential IV push <1% 9,908 $7K
97116 <1% 264 $6K
83735 <1% 4,971 $6K
73110 <1% 339 $6K
85610 <1% 4,210 $5K
96368 <1% 4,427 $5K
96367 <1% 162 $5K
93970 <1% 46 $5K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 55 $5K
73502 <1% 280 $5K
90715 <1% 347 $5K
72100 <1% 269 $5K
80061 Lipid panel <1% 699 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,615 $5K
64483 <1% 14 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 659 $4K
96376 <1% 1,506 $4K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 15 $4K
31575 <1% 16 $4K
81001 <1% 8,376 $4K
73560 <1% 181 $4K
86140 <1% 515 $4K
31231 <1% 13 $3K
0002A <1% 95 $3K
99222 Initial hospital care, per day, moderate complexity <1% 97 $3K
81003 <1% 4,795 $3K
99152 <1% 235 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,538 $3K
J3490 Unclassified drugs <1% 1,925 $3K
70486 <1% 121 $3K
73564 <1% 276 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 127 $3K
0001A <1% 91 $2K
86901 <1% 1,095 $2K
70551 Magnetic resonance imaging, brain; without contrast material <1% 16 $2K
99401 <1% 25 $2K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 14 $2K
76000 <1% 47 $2K
84702 <1% 1,464 $2K
70496 <1% 16 $2K
83880 <1% 1,484 $2K
80069 <1% 277 $2K
93975 <1% 16 $2K
12011 <1% 12 $2K
72128 <1% 128 $2K
81025 <1% 5,309 $2K
82607 <1% 96 $2K
99203 Doctor's office visit, new patient (routine) <1% 64 $2K
83690 <1% 4,383 $1K
82728 <1% 92 $1K
92523 <1% 18 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 379 $1K
97535 Self-care/home management training, each 15 minutes <1% 70 $1K
80143 <1% 1,319 $1K
82077 <1% 1,244 $1K
72170 <1% 140 $1K
87081 <1% 171 $1K
83540 <1% 109 $1K
85018 <1% 750 $943.70
85379 <1% 875 $941.81
87077 <1% 491 $924.33
J1170 Injection, hydromorphone, up to 4 mg <1% 1,423 $904.80
85007 <1% 320 $858.60
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 245 $827.98
87186 <1% 781 $818.98
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,815 $811.27
80076 <1% 485 $807.62
83550 <1% 88 $791.12
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 750 $702.73
87040 <1% 918 $688.33
00731 <1% 270 $682.71
85730 <1% 1,248 $663.44
87634 <1% 120 $615.22
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 214 $589.76
77061 <1% 13 $571.54
46083 <1% 14 $570.48
87631 <1% 26 $568.44
85014 <1% 109 $562.05
93296 <1% 24 $555.16
J7030 Infusion, normal saline solution , 1000 cc <1% 4,742 $535.93
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 1,346 $532.47
99204 Doctor's office visit, new patient (more involved) <1% 13 $528.71
80179 <1% 1,302 $526.70
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 215 $516.85
87075 <1% 823 $516.10
J1644 Injection, heparin sodium, per 1000 units <1% 1,388 $510.74
87070 <1% 355 $508.26
84439 <1% 42 $488.27
82248 <1% 344 $487.46
A9270 Non-covered item or service <1% 8,693 $480.36
C9113 Injection, pantoprazole sodium, per vial <1% 259 $479.88
J1650 Injection, enoxaparin sodium, 10 mg <1% 750 $478.79
0004A <1% 12 $464.12
72040 <1% 13 $439.84
80164 <1% 30 $436.92
73140 <1% 17 $436.10
82746 <1% 49 $409.19
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,322 $359.45
77065 Tomosynthesis, mammo <1% 15 $342.69
88142 <1% 29 $339.42
84132 <1% 599 $333.22
99153 Mod sedat endo service >5yrs <1% 63 $330.62
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 33 $313.28
87800 <1% 104 $297.12
82330 <1% 445 $291.75
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,269 $287.19
84100 <1% 143 $284.64
87205 <1% 331 $266.05
80329 <1% 116 $263.25
76801 <1% 13 $256.50
82550 <1% 207 $229.56
J1815 Injection, insulin, per 5 units <1% 180 $218.78
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 269 $211.44
J2704 Injection, propofol, 10 mg <1% 7,516 $207.05
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 65 $197.07
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,143 $193.17
G0404 Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination <1% 81 $185.52
82140 <1% 37 $177.40
J7999 Compounded drug, not otherwise classified <1% 558 $177.13
J7060 5% dextrose/water (500 ml = 1 unit) <1% 4,600 $168.49
85652 <1% 263 $167.88
82150 <1% 177 $163.90
84481 <1% 12 $158.10
82570 <1% 101 $151.73
82435 <1% 401 $150.94
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 880 $124.38
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,575 $112.85
J3475 Injection, magnesium sulfate, per 500 mg <1% 564 $109.81
J3370 Injection, vancomycin hcl, 500 mg <1% 257 $104.70
94761 <1% 615 $104.23
73090 <1% 14 $101.26
84295 <1% 400 $87.89
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,072 $70.97
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 852 $66.72
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 868 $61.73
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,454 $60.57
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 394 $57.07
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 99 $49.35
86308 <1% 20 $47.57
J0690 Injection, cefazolin sodium, 500 mg <1% 341 $44.42
J1630 Injection, haloperidol, up to 5 mg <1% 160 $44.11
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 673 $41.60
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,073 $37.91
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,078 $37.63
87210 <1% 72 $36.14
86403 <1% 127 $32.29
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,319 $31.28
J2060 Injection, lorazepam, 2 mg <1% 157 $30.90
82010 <1% 17 $28.47
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 145 $28.18
J1040 Injection, methylprednisolone acetate, 80 mg <1% 114 $22.06
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 3,535 $19.87
A4217 Sterile water/saline, 500 ml <1% 370 $19.86
J8540 Dexamethasone, oral, 0.25 mg <1% 136 $17.20
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 16 $15.59
80305 <1% 214 $14.70
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 179 $14.35
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 482 $13.05
J1010 Injection, methylprednisolone acetate, 1 mg <1% 122 $10.92
J1171 Injection, hydromorphone, 0.1 mg <1% 133 $7.74
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 279 $7.32
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 113 $7.30
J7050 Infusion, normal saline solution, 250 cc <1% 232 $6.27
J2470 Injection, pantoprazole sodium, 40 mg <1% 14 $5.56
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 18 $5.20
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 213 $2.56
J3480 Injection, potassium chloride, per 2 meq <1% 31 $2.26
91300 <1% 233 $1.87
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 113 $0.34
3008F 0% 109 $0.00
C1769 Guide wire 0% 166 $0.00
1036F 0% 63 $0.00
76377 0% 93 $0.00
94760 0% 120 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 704 $0.00
84075 0% 30 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 16 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 54 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 18 $0.00
00813 0% 24 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 482 $0.00
84460 0% 30 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 204 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 32 $0.00
29125 0% 21 $0.00
84450 0% 30 $0.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 0% 75 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 15 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 44 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 25 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 45 $0.00
84155 0% 30 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 18 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 30 $0.00
77003 0% 19 $0.00
0753T 0% 19 $0.00
82247 0% 30 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHILLERO, ANTHONY (DIRECTOR, FP&A)
Same official

Other billing entities under SCHILLERO, ANTHONY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.